z-logo
open-access-imgOpen Access
Adjuvant therapy in renal cell carcinoma—is pharmacogenomics assessment another element to select our patients?
Author(s) -
Vincenzo Di Nunno,
Veronica Mollica,
Lidia Gatto,
Matteo Santoni,
Giulia Sorgentoni,
Nicola Battelli,
Francesco Massari
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.02.31
Subject(s) - renal cell carcinoma , pharmacogenomics , adjuvant , medicine , adjuvant therapy , oncology , clinical trial , bioinformatics , pharmacology , cancer , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom